JP2011063627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011063627A5 JP2011063627A5 JP2010293163A JP2010293163A JP2011063627A5 JP 2011063627 A5 JP2011063627 A5 JP 2011063627A5 JP 2010293163 A JP2010293163 A JP 2010293163A JP 2010293163 A JP2010293163 A JP 2010293163A JP 2011063627 A5 JP2011063627 A5 JP 2011063627A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- ethyl
- copolymer
- methacrylate
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940079593 drug Drugs 0.000 claims 23
- 239000003814 drug Substances 0.000 claims 23
- 229920001577 copolymer Polymers 0.000 claims 17
- 239000007771 core particle Substances 0.000 claims 16
- 239000008187 granular material Substances 0.000 claims 15
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 14
- 230000000873 masking effect Effects 0.000 claims 12
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 10
- 229940117841 methacrylic acid copolymer Drugs 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 9
- 239000011248 coating agent Substances 0.000 claims 8
- 238000000576 coating method Methods 0.000 claims 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 7
- 239000004386 Erythritol Substances 0.000 claims 7
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 7
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 7
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 7
- 235000019414 erythritol Nutrition 0.000 claims 7
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 7
- 229940009714 erythritol Drugs 0.000 claims 7
- 239000008101 lactose Substances 0.000 claims 7
- 229960001375 lactose Drugs 0.000 claims 7
- 239000000845 maltitol Substances 0.000 claims 7
- 235000010449 maltitol Nutrition 0.000 claims 7
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 7
- 229940035436 maltitol Drugs 0.000 claims 7
- 235000010355 mannitol Nutrition 0.000 claims 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims 7
- 229940074410 trehalose Drugs 0.000 claims 7
- 239000000811 xylitol Substances 0.000 claims 7
- 235000010447 xylitol Nutrition 0.000 claims 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 7
- 229960002675 xylitol Drugs 0.000 claims 7
- 229920000642 polymer Polymers 0.000 claims 6
- 235000019658 bitter taste Nutrition 0.000 claims 5
- 230000001747 exhibiting effect Effects 0.000 claims 5
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 4
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 claims 3
- VDHAWDNDOKGFTD-MRXNPFEDSA-N cinacalcet Chemical compound N([C@H](C)C=1C2=CC=CC=C2C=CC=1)CCCC1=CC=CC(C(F)(F)F)=C1 VDHAWDNDOKGFTD-MRXNPFEDSA-N 0.000 claims 3
- 229960003315 cinacalcet Drugs 0.000 claims 3
- 229960004114 olopatadine Drugs 0.000 claims 3
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229960004394 topiramate Drugs 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- XBIUYJRCOQYZLZ-UHFFFAOYSA-N C(C(=C)C)(=O)[O-].[Cl-].C[NH+](C)C.C(C(=C)C)(=O)OC.C(C=C)(=O)OCC.C[NH+](C)C Chemical compound C(C(=C)C)(=O)[O-].[Cl-].C[NH+](C)C.C(C(=C)C)(=O)OC.C(C=C)(=O)OCC.C[NH+](C)C XBIUYJRCOQYZLZ-UHFFFAOYSA-N 0.000 claims 1
- -1 ethyl methyl Chemical group 0.000 claims 1
- XPNLOZNCOBKRNJ-UHFFFAOYSA-N ethyl prop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C=C.COC(=O)C(C)=C XPNLOZNCOBKRNJ-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000011812 mixed powder Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010293163A JP4803686B2 (ja) | 2010-08-31 | 2010-12-28 | 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010194755 | 2010-08-31 | ||
| JP2010194755 | 2010-08-31 | ||
| JP2010293163A JP4803686B2 (ja) | 2010-08-31 | 2010-12-28 | 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011063627A JP2011063627A (ja) | 2011-03-31 |
| JP2011063627A5 true JP2011063627A5 (enExample) | 2011-06-30 |
| JP4803686B2 JP4803686B2 (ja) | 2011-10-26 |
Family
ID=43950218
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010293163A Active JP4803686B2 (ja) | 2010-08-31 | 2010-12-28 | 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠 |
| JP2012531710A Active JP5752132B2 (ja) | 2010-08-31 | 2011-04-08 | 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012531710A Active JP5752132B2 (ja) | 2010-08-31 | 2011-04-08 | 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130224295A1 (enExample) |
| EP (1) | EP2614816A4 (enExample) |
| JP (2) | JP4803686B2 (enExample) |
| KR (1) | KR20130141474A (enExample) |
| WO (1) | WO2012029348A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2612657B1 (en) * | 2010-08-31 | 2023-08-09 | Kyowa Kirin Co., Ltd. | Orodispersible tablet |
| JP5690925B2 (ja) * | 2011-04-28 | 2015-03-25 | 持田製薬株式会社 | 口腔内崩壊性に優れたコーティング組成物 |
| WO2012173226A1 (ja) * | 2011-06-17 | 2012-12-20 | 株式会社 三和化学研究所 | ポリスチレンスルホン酸塩含有医薬製剤 |
| JP5756727B2 (ja) * | 2011-09-30 | 2015-07-29 | ハウス食品グループ本社株式会社 | 顆粒 |
| WO2013125350A1 (ja) * | 2012-02-23 | 2013-08-29 | フロイント産業株式会社 | 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠 |
| JP6004702B2 (ja) * | 2012-03-30 | 2016-10-12 | 小林製薬株式会社 | 不快味が軽減された固形製剤の製造方法 |
| FI126168B (en) | 2012-09-18 | 2016-07-29 | Novaldmedical Ltd Oy | A method for coating pharmaceutical substrates |
| JP6012373B2 (ja) * | 2012-09-28 | 2016-10-25 | 杏林製薬株式会社 | 口腔内崩壊錠 |
| KR101340733B1 (ko) | 2012-12-31 | 2013-12-12 | (주) 에프엔지리서치 | 신규한 마이크로그래뉼 제형 |
| KR101352689B1 (ko) * | 2012-12-31 | 2014-01-17 | (주) 에프엔지리서치 | 불연속상과 연속상으로 이루어지는 응집단위를 포함하는 마이크로그래뉼 제형 |
| JP5836980B2 (ja) | 2013-01-11 | 2015-12-24 | 信越化学工業株式会社 | 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法 |
| EP2979697A4 (en) * | 2013-03-26 | 2016-11-30 | Kissei Pharmaceutical | PREPARATION FOR ORAL ADMINISTRATION WITH MASKED BITTERNITY OF SILODOSINE |
| KR101610894B1 (ko) | 2014-05-08 | 2016-04-08 | (주) 네추럴웨이 | 맛이 차폐된 비타민 c 과립 |
| JP6147711B2 (ja) * | 2014-05-26 | 2017-06-14 | 富士フイルム株式会社 | 医薬用組成物及びその製造方法、並びに口腔内崩壊錠及びその製造方法 |
| WO2017115764A1 (ja) * | 2015-12-28 | 2017-07-06 | 日本新薬株式会社 | 圧縮成型製剤 |
| EP3419659A1 (en) | 2016-02-23 | 2019-01-02 | The Regents of the University of Colorado, A Body Corporate | Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens |
| EP3241549A1 (en) * | 2016-05-02 | 2017-11-08 | Sun Pharmaceutical Industries Limited | Sprinkle composition of cinacalcet |
| JP6778051B2 (ja) * | 2016-08-18 | 2020-10-28 | 沢井製薬株式会社 | オセルタミビルリン酸塩含有医薬組成物 |
| KR102647471B1 (ko) * | 2016-10-10 | 2024-03-14 | 한미약품 주식회사 | 고미 및 이물감이 개선된 에르도스테인 과립제제 |
| EP3563845B1 (en) * | 2016-12-28 | 2023-03-22 | FUJIFILM Toyama Chemical Co., Ltd. | Pharmaceutical composition |
| JP7182356B2 (ja) * | 2017-07-05 | 2022-12-02 | 日本ケミファ株式会社 | 口腔内崩壊錠及びその製造方法 |
| WO2019039420A1 (ja) | 2017-08-21 | 2019-02-28 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
| TWI795462B (zh) * | 2017-11-17 | 2023-03-11 | 日商鹽野義製藥股份有限公司 | 光安定性及溶出性優異的醫藥製劑 |
| KR102496427B1 (ko) | 2018-01-16 | 2023-02-06 | 어플라이드 머티어리얼스, 인코포레이티드 | 금속 산화물로 캡슐화된 약물 조성물들 및 그의 제조 방법들 |
| KR102120720B1 (ko) * | 2018-07-16 | 2020-06-10 | 연성정밀화학(주) | 날푸라핀 함유 구강붕해정 |
| WO2020032159A1 (ja) * | 2018-08-10 | 2020-02-13 | 日本臓器製薬株式会社 | 粒状組成物及びその製造方法 |
| CN110882223A (zh) * | 2018-09-11 | 2020-03-17 | 海南中济医药科技有限公司 | 直接压片的盐酸奥洛他定片剂配方 |
| CN113041231B (zh) * | 2019-12-26 | 2024-03-26 | 鲁南制药集团股份有限公司 | 一种替比培南酯细粒剂组合物及其制备方法 |
| TWI870622B (zh) | 2020-10-02 | 2025-01-21 | 美商應用材料股份有限公司 | 製備氧化矽塗佈藥品的低溫處理 |
| WO2023056304A1 (en) | 2021-09-30 | 2023-04-06 | Applied Materials, Inc. | Low temperature silicon oxide coating for pharmaceutical applications |
| CN120360958B (zh) * | 2025-05-27 | 2025-10-28 | 江苏和汇医药科技有限公司 | 一种奥洛他定口腔快速崩解片组合物及其制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
| FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
| RU2003129506A (ru) * | 2001-03-06 | 2005-03-10 | Киова Хакко Когио Ко., Лтд. (Jp) | Быстрораспадающаяся во рту таблетка |
| US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
| EP1656117A1 (en) * | 2003-08-11 | 2006-05-17 | Merck Frosst Canada Ltd. | Flavored taste-masked pharmaceutical formulation made using a one-step coating process |
| EP1695699A4 (en) * | 2003-12-09 | 2012-08-22 | Dainippon Sumitomo Pharma Co | MEDICINAL GRAINS AND THE GRAINS CONTAINING SOLID PREPARATIONS |
| US8663694B2 (en) * | 2005-03-16 | 2014-03-04 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| TWI367756B (en) * | 2005-05-20 | 2012-07-11 | Sankyo Co | A film-coated drug product comprising dextrose |
| JP4439499B2 (ja) * | 2005-08-01 | 2010-03-24 | 大日本住友製薬株式会社 | アムロジピン含有粒子およびそれからなる口腔内崩壊錠 |
| US20070134493A1 (en) * | 2005-12-08 | 2007-06-14 | Kanji Meghpara | Compositions and capsules with stable hydrophilic layers |
| EP2026768B1 (en) * | 2006-06-01 | 2018-02-28 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
| JP2008013480A (ja) * | 2006-07-05 | 2008-01-24 | Sawai Pharmaceutical Co Ltd | 薬物含有微粒子およびその製造方法 |
| KR20090037951A (ko) * | 2006-07-25 | 2009-04-16 | 교와 가부시키가이샤 | 당의 제제 및 그의 제조 방법 |
| JP2008050324A (ja) * | 2006-08-28 | 2008-03-06 | Ohara Yakuhin Kogyo Kk | 苦味遮蔽組成物。 |
| JP5405752B2 (ja) * | 2007-01-31 | 2014-02-05 | 大日本住友製薬株式会社 | 被覆された薬物含有粒子および該粒子を含む固形製剤 |
| JP5228359B2 (ja) * | 2007-04-12 | 2013-07-03 | ニプロ株式会社 | 主薬粒子及びその製造方法ならびに口腔内崩壊錠 |
| JP2009114113A (ja) * | 2007-11-06 | 2009-05-28 | Nipro Corp | 口腔内崩壊錠及びその製造方法 |
| WO2009078034A2 (en) * | 2007-11-26 | 2009-06-25 | Rubicon Research Private Limited | Oral disintegrating tablets of ropinirole hydrochloride |
| CN103919742B (zh) * | 2008-11-25 | 2017-04-12 | 田边三菱制药株式会社 | 口腔速崩片及其制备方法 |
-
2010
- 2010-12-28 JP JP2010293163A patent/JP4803686B2/ja active Active
-
2011
- 2011-04-08 US US13/820,099 patent/US20130224295A1/en not_active Abandoned
- 2011-04-08 WO PCT/JP2011/058919 patent/WO2012029348A1/ja not_active Ceased
- 2011-04-08 EP EP11821366.9A patent/EP2614816A4/en active Pending
- 2011-04-08 JP JP2012531710A patent/JP5752132B2/ja active Active
- 2011-04-08 KR KR1020137008136A patent/KR20130141474A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011063627A5 (enExample) | ||
| KR101500769B1 (ko) | 위액 내성인 활성 물질 매트릭스를 포함하는 펠렛 | |
| RU2239417C2 (ru) | Опиоидные анальгетики с контролируемым высвобождением активных веществ | |
| FI3287124T3 (fi) | Ketamiinin oraalinen annosmuoto | |
| JP2012528845A5 (enExample) | ||
| RU2017137643A (ru) | Составы l-орнитин фенилацетата | |
| JP2017019858A5 (enExample) | ||
| ME02687B (me) | Dozni oblik otporan na promene | |
| CN1249950A (zh) | 药学活性颗粒的制备 | |
| EA031255B1 (ru) | Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения | |
| JP2008520736A5 (enExample) | ||
| JP2017532363A5 (enExample) | ||
| WO2015132708A1 (en) | Pharmaceutical composition of roflumilast | |
| WO2012053785A3 (ko) | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 | |
| JP2018515506A5 (enExample) | ||
| CA2797551A1 (en) | Melt-granulated fingolimod | |
| JP2014530802A5 (enExample) | ||
| RU2015138784A (ru) | Фармацевтическая композиция в виде мультичастиц, содержащая множество гранул двух видов | |
| CN105769794B (zh) | 一种盐酸美金刚缓释微丸片剂及其制备方法 | |
| US9861577B2 (en) | Orally disintegrating tablet | |
| JP2015120758A5 (enExample) | ||
| CN104706604A (zh) | 一种吡仑帕奈冻干口崩片及其制备方法 | |
| CN105769773B (zh) | 洛索洛芬钠缓释微丸 | |
| CN104546732A (zh) | 一种右旋布洛芬缓释片及其制备工艺 | |
| CN110381926A (zh) | 新型剂型 |